hydroxyurea has been researched along with Mucositis, Oral in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present a case of oral ulceration in a patient with essential thrombocythaemia, that proved to be secondary to treatment with hydroxyurea." | 8.80 | Oral ulcers caused by hydroxyurea. ( Lindsey, L; Paleri, V, 2000) |
| "The aim of this study was to evaluate the efficacy and toxicity profile of the cyclophosphamide, hydroxyurea, actinomycin D, methotrexate, and vincristine (CHAMOC) regimen in the treatment of high-risk gestational trophoblastic neoplasia (GTN)." | 7.81 | Cyclophosphamide, hydroxyurea, actinomycin D, methotrexate, and vincristine in the treatment of gestational trophoblastic neoplasia. ( Chan, KK; Chu, MM; Ma, Y; Ngan, HY; Tse, KY, 2015) |
| "A consecutive sample of 29 patients with advanced oropharyngeal or hypopharyngeal cancer who were treated with intravenous hydroxyurea and concomitant hyperfractionated, accelerated radiotherapy." | 5.11 | Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma. ( Beitler, JJ; Goldman, SY; Smith, RV; Wadler, SS, 2004) |
| "We present a case of oral ulceration in a patient with essential thrombocythaemia, that proved to be secondary to treatment with hydroxyurea." | 4.80 | Oral ulcers caused by hydroxyurea. ( Lindsey, L; Paleri, V, 2000) |
| "The aim of this study was to evaluate the efficacy and toxicity profile of the cyclophosphamide, hydroxyurea, actinomycin D, methotrexate, and vincristine (CHAMOC) regimen in the treatment of high-risk gestational trophoblastic neoplasia (GTN)." | 3.81 | Cyclophosphamide, hydroxyurea, actinomycin D, methotrexate, and vincristine in the treatment of gestational trophoblastic neoplasia. ( Chan, KK; Chu, MM; Ma, Y; Ngan, HY; Tse, KY, 2015) |
| "Oral hydroxyurea (HU) was added to a regimen of 5-fluorouracil (5-FU) plus leucovorin (LCV) administered as a continuous 24-hour infusion for 14 days." | 2.67 | Dual modulation of 5-fluorouracil using leucovorin and hydroxyurea. A phase I trial. ( Anderson, N; Bern, M; Coco, F; Gonsalves, L; Lokich, J; Moore, C; Zipoli, T, 1991) |
| " Acral erythema is another cutaneous side effect that is relatively specific to chemotherapy and is often dose-related." | 2.42 | Mucocutaneous side effects of antineoplastic chemotherapy. ( Bessis, D; Dereure, O; Guillot, B, 2004) |
| "Hydroxyurea is an active single agent in squamous cell cancer of the head and neck." | 1.28 | Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer. ( Haraf, DJ; Panje, WR; Schilsky, RL; Vokes, EE; Weichselbaum, RR, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, MM | 1 |
| Ma, Y | 1 |
| Tse, KY | 1 |
| Chan, KK | 1 |
| Ngan, HY | 1 |
| Smith, RV | 1 |
| Goldman, SY | 1 |
| Beitler, JJ | 1 |
| Wadler, SS | 1 |
| Guillot, B | 1 |
| Bessis, D | 1 |
| Dereure, O | 1 |
| Vaughan, WP | 1 |
| Kris, E | 1 |
| Vose, J | 1 |
| Bierman, PJ | 1 |
| Gwilt, P | 1 |
| Armitage, JO | 1 |
| Brincker, H | 1 |
| Christensen, BE | 1 |
| Paleri, V | 1 |
| Lindsey, L | 1 |
| Lerner, HJ | 1 |
| Vokes, EE | 2 |
| Haraf, DJ | 1 |
| Panje, WR | 2 |
| Schilsky, RL | 2 |
| Weichselbaum, RR | 2 |
| Lokich, J | 1 |
| Anderson, N | 1 |
| Bern, M | 1 |
| Coco, F | 1 |
| Zipoli, T | 1 |
| Moore, C | 1 |
| Gonsalves, L | 1 |
| Mick, R | 1 |
| Awan, AM | 1 |
| Moran, WJ | 1 |
| Goldman, MD | 1 |
| Tybor, AG | 1 |
| Levantine, A | 1 |
| Almeyda, J | 1 |
3 reviews available for hydroxyurea and Mucositis, Oral
| Article | Year |
|---|---|
Mucocutaneous side effects of antineoplastic chemotherapy.
Topics: Alopecia; Antineoplastic Agents; Drug Eruptions; Hidradenitis; Humans; Hydroxyurea; Mucous Membrane; | 2004 |
Oral ulcers caused by hydroxyurea.
Topics: Aged; Anemia; Humans; Hydroxyurea; Male; Mouth Mucosa; Nucleic Acid Synthesis Inhibitors; Oral Ulcer | 2000 |
Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
Topics: Alopecia; Aminopterin; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Busulfan; Chlor | 1974 |
3 trials available for hydroxyurea and Mucositis, Oral
| Article | Year |
|---|---|
Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Deglutition Disorders; Dose Fractiona | 2004 |
Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carm | 1995 |
Dual modulation of 5-fluorouracil using leucovorin and hydroxyurea. A phase I trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 1991 |
5 other studies available for hydroxyurea and Mucositis, Oral
| Article | Year |
|---|---|
Cyclophosphamide, hydroxyurea, actinomycin D, methotrexate, and vincristine in the treatment of gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Female; Gesta | 2015 |
Acute mucocutaneous toxicity following high-dose hydroxyurea.
Topics: Acute Disease; Adult; Drug Eruptions; Humans; Hydroxyurea; Male; Stomatitis | 1993 |
Concomitant hydroxyurea and irradiation. Clinical experience with 100 patients with advanced head and neck cancer at Pennsylvania hospital.
Topics: Carcinoma, Squamous Cell; Cell Division; Cell Line; DNA, Neoplasm; Head and Neck Neoplasms; Humans; | 1977 |
Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer.
Topics: Administration, Oral; Bone Marrow; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Fluorouracil; H | 1992 |
Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcino | 1989 |